Skip to main content
main-content
Erschienen in: best practice onkologie 11/2021

19.10.2021 | Nierenkarzinom | Topic

Tumorerkrankungen von Dialysepatienten und vor Nierentransplantation

verfasst von: S. Delecluse

Erschienen in: best practice onkologie | Ausgabe 11/2021

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die chronische und terminale Niereninsuffizienz ist mit einem allgemeinen Anstieg der Tumorinzidenz dieser Patienten assoziiert. Häufig treten Tumoren des Urogenitaltrakts, insbesondere Nierenzellkarzinome, auf. Ein Screening analog zur gesunden Normalbevölkerung durchzuführen erscheint intuitiv richtig, scheint aber nur für Patienten mit langer Lebenserwartung vorteilhaft zu sein. Die Validität der eingesetzten Screeningmethoden und die per se schon außergewöhnlich hohe Strahlenbelastung niereninsuffizienter Patienten sind hierbei limitierende Faktoren. Für Patienten mit Transplantationswunsch kann das Auftreten eines Prätransplanttumors schwerwiegende Folgen haben und eine Verlängerung der Wartezeit oder sogar die Unmöglichkeit der Transplantation bedeuten. Die größte Herausforderung in dieser Situation ist die Festlegung der notwendigen tumorfreien Wartezeit vor einer Transplantation.
Literatur
1.
Zurück zum Zitat Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354(9173):93–99 CrossRef Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354(9173):93–99 CrossRef
2.
Zurück zum Zitat Butler AM, Olshan AF, Kshirsagar AV, Edwards JK, Nielsen ME, Wheeler SB et al (2015) Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996–2009. Am J Kidney Dis 65(5):763–772 CrossRef Butler AM, Olshan AF, Kshirsagar AV, Edwards JK, Nielsen ME, Wheeler SB et al (2015) Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996–2009. Am J Kidney Dis 65(5):763–772 CrossRef
3.
Zurück zum Zitat Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR et al (2009) The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 24(10):3225–3231 CrossRef Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR et al (2009) The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 24(10):3225–3231 CrossRef
4.
Zurück zum Zitat Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN et al (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30(2):141–153 CrossRef Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN et al (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30(2):141–153 CrossRef
5.
Zurück zum Zitat Kondo T, Sasa N, Yamada H, Takagi T, Iizuka J, Kobayashi H et al (2018) Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: central pathology results according to the 2016 WHO classification in a multi-institutional study. Pathol Int 68(10):543–549 CrossRef Kondo T, Sasa N, Yamada H, Takagi T, Iizuka J, Kobayashi H et al (2018) Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: central pathology results according to the 2016 WHO classification in a multi-institutional study. Pathol Int 68(10):543–549 CrossRef
6.
Zurück zum Zitat Tickoo SK et al (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30(2):141–153 CrossRef Tickoo SK et al (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30(2):141–153 CrossRef
7.
Zurück zum Zitat Inoue H, Nonomura N, Kojima Y, Shiba M, Oka D, Arai Y et al (2007) Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis. Nephrol Dial Transplant 22(7):2052–2055 CrossRef Inoue H, Nonomura N, Kojima Y, Shiba M, Oka D, Arai Y et al (2007) Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis. Nephrol Dial Transplant 22(7):2052–2055 CrossRef
8.
Zurück zum Zitat Akmal M, Sawelson S, Karubian F, Gadallah M (1994) The prevalence and significance of occult blood loss in patients with predialysis advanced chronic renal failure (CRF), or receiving dialytic therapy. Clin Nephrol 42(3):198–202 PubMed Akmal M, Sawelson S, Karubian F, Gadallah M (1994) The prevalence and significance of occult blood loss in patients with predialysis advanced chronic renal failure (CRF), or receiving dialytic therapy. Clin Nephrol 42(3):198–202 PubMed
9.
Zurück zum Zitat Bini EJ, Kinkhabwala A, Goldfarb DS (2006) Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens. Am J Kidney Dis 48(4):580–586 CrossRef Bini EJ, Kinkhabwala A, Goldfarb DS (2006) Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens. Am J Kidney Dis 48(4):580–586 CrossRef
10.
Zurück zum Zitat Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713–735 CrossRef Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713–735 CrossRef
11.
Zurück zum Zitat Castellanos M, Varma S, Ahern K, Grosso SJ, Buchbinder S, D’Angelo D et al (2006) Increased breast calcifications in women with ESRD on dialysis: implications for breast cancer screening. Am J Kidney Dis 48(2):301–306 CrossRef Castellanos M, Varma S, Ahern K, Grosso SJ, Buchbinder S, D’Angelo D et al (2006) Increased breast calcifications in women with ESRD on dialysis: implications for breast cancer screening. Am J Kidney Dis 48(2):301–306 CrossRef
12.
Zurück zum Zitat Walter LC, Lindquist K, O’Hare AM, Johansen KL (2006) Targeting screening mammography according to life expectancy among women undergoing dialysis. Arch Intern Med 166(11):1203–1208 CrossRef Walter LC, Lindquist K, O’Hare AM, Johansen KL (2006) Targeting screening mammography according to life expectancy among women undergoing dialysis. Arch Intern Med 166(11):1203–1208 CrossRef
13.
Zurück zum Zitat Tarhan F, Orcun A, Kucukercan I, Camursoy N, Kuyumcuoglu U (2007) Effect of hemodialysis on serum complexed prostate-specific antigen levels. Scand J Urol Nephrol 41(5):382–386 CrossRef Tarhan F, Orcun A, Kucukercan I, Camursoy N, Kuyumcuoglu U (2007) Effect of hemodialysis on serum complexed prostate-specific antigen levels. Scand J Urol Nephrol 41(5):382–386 CrossRef
14.
Zurück zum Zitat Cohen EP, Krzesinski JM, Launay-Vacher V, Sprangers B (2015) Onco-nephrology: core curriculum 2015. Am J Kidney Dis 66(5):869–883 CrossRef Cohen EP, Krzesinski JM, Launay-Vacher V, Sprangers B (2015) Onco-nephrology: core curriculum 2015. Am J Kidney Dis 66(5):869–883 CrossRef
15.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9(3):S1–155 Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9(3):S1–155
16.
Zurück zum Zitat Acuna SA, Huang JW, Daly C, Shah PS, Kim SJ, Baxter NN (2017) Outcomes of solid organ transplant recipients with preexisting malignancies in remission: a systematic review and meta-analysis. Transplantation 101(3):471–481 CrossRef Acuna SA, Huang JW, Daly C, Shah PS, Kim SJ, Baxter NN (2017) Outcomes of solid organ transplant recipients with preexisting malignancies in remission: a systematic review and meta-analysis. Transplantation 101(3):471–481 CrossRef
17.
Zurück zum Zitat Penn I (1997) Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant 2(4):14–17 PubMed Penn I (1997) Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant 2(4):14–17 PubMed
18.
Zurück zum Zitat Brattstrom C, Granath F, Edgren G, Smedby KE, Wilczek HE (2013) Overall and cause-specific mortality in transplant recipients with a pretransplantation cancer history. Transplantation 96(3):297–305 CrossRef Brattstrom C, Granath F, Edgren G, Smedby KE, Wilczek HE (2013) Overall and cause-specific mortality in transplant recipients with a pretransplantation cancer history. Transplantation 96(3):297–305 CrossRef
19.
Zurück zum Zitat Unterrainer C, Opelz G, Dohler B, Susal C, Collaborative Transplant Study (2019) Pretransplant cancer in kidney recipients in relation to recurrent and de novo cancer incidence posttransplantation and implications for graft and patient survival. Transplantation 103(3):581–587 CrossRef Unterrainer C, Opelz G, Dohler B, Susal C, Collaborative Transplant Study (2019) Pretransplant cancer in kidney recipients in relation to recurrent and de novo cancer incidence posttransplantation and implications for graft and patient survival. Transplantation 103(3):581–587 CrossRef
20.
Zurück zum Zitat EBPG (European Expert Group on Renal Transplantation), European Renal Association (ERA-EDTA), European Society for Organ Transplantation (ESOT) (2000) European best practice guidelines for renal transplantation (part 1). Nephrol Dial Transplant 15(7):1–85 EBPG (European Expert Group on Renal Transplantation), European Renal Association (ERA-EDTA), European Society for Organ Transplantation (ESOT) (2000) European best practice guidelines for renal transplantation (part 1). Nephrol Dial Transplant 15(7):1–85
21.
Zurück zum Zitat Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D et al (2001) The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant 1(2):3–95 PubMed Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D et al (2001) The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant 1(2):3–95 PubMed
Metadaten
Titel
Tumorerkrankungen von Dialysepatienten und vor Nierentransplantation
verfasst von
S. Delecluse
Publikationsdatum
19.10.2021

Weitere Artikel der Ausgabe 11/2021

best practice onkologie 11/2021 Zur Ausgabe

Praxis- und Klinikmanagement

Berufliche Trauer

onko-aktuell

onko-aktuell

Editorial

Editorial

Neu im Fachgebiet Onkologie

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.